• Home
• About
• Alzheimer’s Disease
• Dementia
• FAQ’s
• Research Centers
• Studies
• Testimonials

Stay Informed

↑ Grab this Headline Animator

Medical Links

• Abbott Laboratories
• Adult Care Advisors
• Alcoeur Gardens - Special care for the Alzheimer’s Disease patient
• Alzheimer’s Disease information provided by Novartis Pharmaceuticals - For patients and caregivers
• Alzheimer’s Foundation of America
• Alzheimer’s Foundation of America - Support resource for patients, cargivers and health care professionals
• Alzheimer’s Disease Clinical Trials
• Bristol-Myers Squibb
• CLINICAL RESEARCH TRIALS IN ALZHEIMER'S DISEASE - All current AD trials in the United States
• Clinical Trials at Memory Enhancement Centers of America - Clinical Research Trials
• COVANCE
• Eisai
• Elan Corporation
• Geriatric Medical Center of Dr. Sanjiv, Sharma, MD - First class geriatric medical care for seniors
• ICON Central Laboratories
• Lori Wright Consulting - CNS research consulting firm
• Neuronascent
• Novartis
• Pfizer
• Quintiles
• Sanofi-Aventis
• The Regency at Dover (Toms River, NJ) - “A Premier Senior Club”
• Wyeth Pharmaceuticals

Links

• Directions to the Center
• Sea Spray Designs LLC

Search

Joel S. Ross, MD

MD FACP AGSF CMD CPI

President and Founder

Memory Enhancement Center

of America, Inc.

4 Industrial Way West, 2nd Floor

Eatontown, New Jersey 07724

732.571.1535

Alzheimer’s Disease

Will Dimebon be the next FDA approved Drug for AD?

I have been very actively researching Dimebon in clinical research studies under strict FDA and industry guidelines, and saw the below article and felt my readers would be most interested in learning more about an “outsider” looking in at the potential for this drug if FDA approved for Alzheimer’s Disease.
For the Treatment of Alzheimer’s Disease, [...]

Donepezil, galantamine, rivastigmine (review) and memantine for the treatment of Alzheimer’s disease

This extract does not constitute the full guidance on this subject and may be misleading if read in isolation. Readers should always therefore read the guidance as a whole, which can be found by clicking on the link: http://guidance.nice.org.uk/TA111/Guidance
Title: )
Date issued: September 2007
1. Guidance
This guidance applies to donepezil, galantamine, rivastigmine and memantine within the marketing [...]

Memory Enhancement Center(s) now open in Toms River NJ and Brooklyln NY

The Memory Enhancement Centers of America are very proud to have added the Toms River NJ site headed by Dr. Sanjiv Sharma, MD (board certified fellowship trained geriatrician) and the Memory Enhancement Center of Brooklyn, headed by Dr. Jeffrey Ben-Zvi, MD (board certified in geriatric medicine).
These two centers of excellence will now provide even more [...]

Is Namenda (Memantine) Really Helpful for Alzheimer’s Disease Patients?

 
 Benefit Of Memantine In The Treatment Of Alzheimer’s Disease Not Proven
ScienceDaily (Oct. 28, 2009) — There is no scientific proof that patients with moderate or severe Alzheimer’s disease benefit from drugs containing the agent memantine. This is the conclusion in the final report that the Institute for Quality and Efficiency in Health Care (IQWiG) published [...]

Are the FDA Approved Alzheimer’s Disease Drugs Safe for Older Patients?

Safety of Cholinesterase Inhibitors Under Scrutiny
5 October 2009. In a report highlighting the cardiac risks of cholinesterase inhibitors, epidemiologists at St. Michael’s Hospital and the University of Toronto in Ontario, Canada, have found that elderly people starting on the medicines had twice the risk of hospitalization due to low heart rate (bradycardia). The findings also [...]